Partnership for Health (PfH) is an evidence-based, clinician-delivered HIV prevention program conducted in the United States for HIV-positive patients. This intervention strives to reduce risky sexual behaviors through provider-patient discussions on safer sex and HIV status disclosure. A cross-sectional, mixed-methods design was used to evaluate the dissemination and implementation of PfH, including training evaluations, an online trainee survey, and interviews with national trainers for PfH. Descriptive statistics were calculated with the categorical data, whereas thematic analysis was completed with the qualitative data. Between 2007 and 2013, PfH was disseminated to 776 individuals from 104 different organizations in 21 states/territories. The smallest proportion of trainees was physicians (6.9%). More than three-fourths of survey respondents (78.6%) reported using PfH, but less than one-third (31.8%) used the intervention with every patient. The PfH training supports the implementation of the intervention; however, challenges were experienced in clinician engagement. Tailored strategies to recruit and train clinicians providing care to HIV-positive patients are required.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1097/PHH.0000000000000340 | DOI Listing |
NIHR Open Res
January 2025
University of Plymouth School of Nursing and Midwifery, Plymouth, England, UK.
Background: During pregnancy, labour and early motherhood, most women in the UK receive care from different midwives. NHS policy change in England sought to introduce a model of care whereby each woman is cared for by the same midwife throughout antenatal, intrapartum and postnatal periods, supported by a small team of midwives to cover off-duty periods. This model is called the Midwifery Continuity of Carer (MCoC).
View Article and Find Full Text PDFJ Palliat Med
March 2025
South West Sydney Clinical Campuses, Faculty of Medicine and Health, University of New South Wales (UNSW) Sydney, Kensington, New South Wales, Australia.
Medicinal cannabis clinical trials in palliative medicine present unique and complex challenges encompassing ethical, legal, and feasibility obligations, making consumer input essential. However, little is known about the consumer contribution in the medicinal cannabis research space. We present a case report on consumer contribution in the design and conduct of a Phase I/IIb medicinal cannabis clinical trial for anorexia in people with advanced cancer.
View Article and Find Full Text PDFArch Soc Esp Oftalmol (Engl Ed)
March 2025
Universidad de Valladolid, Valladolid, Spain; Facultad de Enfermería, Universidad de Valladolid, Valladolid, Spain; IOBA (Instituto Universitario de Oftalmobiología Aplicada), Universidad de Valladolid, Valladolid, Spain.
The implementation of the Medical Device Regulation and Royal Decree 192/2023 not only requires manufacturers to enhance safety measures in the production of medical devices but is also complemented by additional regulations impacting hospitals, clinics, and healthcare personnel. Among these is the requirement to identify and report serious incidents to the Spanish Agency of Medicines and Medical Devices (AEMPS). To establish a baseline and evaluate the dissemination efforts of these concepts at the level of scientific societies and other organizations, serious incidents involving ophthalmic medical devices reported to AEMPS since 2018 and subject to health alerts have been identified.
View Article and Find Full Text PDFJ Prev (2022)
March 2025
FINDER Akademie, Berlin, Germany.
The European Prevention Curriculum (EUPC) is a European initiative to promote professional and quality-assured substance use prevention. In Austria, the EUPC is trialled via a three-year pilot project to explore its appropriateness and long-term feasibility. We report on the first two years of EUPC project implementation as part of a Special Issue on EUPC implementation practice and lessons learnt.
View Article and Find Full Text PDFBMC Anesthesiol
March 2025
Medical Faculty Heidelberg, Department of Anesthesiology, Heidelberg University, Heidelberg, Germany.
Background: Children, especially neonates and infants, are at particularly high risk of hypoxemia during induction of anesthesia. The addition of nasal apnoeic oxygenation (ApOx) during tracheal intubation should prolong safe apnoea time without desaturation and reduce the risk of hypoxemia. Despite the recommendations in the relevant European guidelines, their implementation in pediatric anesthesia in Germany is not yet known.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!